Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
129.76
+0.81 (0.63%)
At close: Feb 26, 2026, 4:00 PM EST
129.80
+0.04 (0.03%)
After-hours: Feb 26, 2026, 6:10 PM EST
Zoetis Revenue
In the year 2025, Zoetis had annual revenue of $9.47B with 2.28% growth. Zoetis had revenue of $2.39B in the quarter ending December 31, 2025, with 3.02% growth.
Revenue (ttm)
$9.47B
Revenue Growth
+2.28%
P/S Ratio
5.78
Revenue / Employee
$652,897
Employees
14,500
Market Cap
54.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.47B | 211.00M | 2.28% |
| Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
| Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
| Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
| Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
| Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
| Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
| Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
| Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
| Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
| Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
| Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
| Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
| Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
| Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
| Dec 31, 2010 | 3.58B | 822.00M | 29.78% |
| Dec 31, 2009 | 2.76B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 28.48B |
| Teva Pharmaceutical Industries | 17.26B |
| Haleon | 15.10B |
| Viatris | 14.12B |
| Elanco Animal Health | 4.59B |
| Dr. Reddy's Laboratories | 3.85B |
| United Therapeutics | 3.13B |
| Neurocrine Biosciences | 2.86B |
ZTS News
- 2 hours ago - Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript - Seeking Alpha
- 2 days ago - Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit - Business Wire
- 10 days ago - Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 10 days ago - Zoetis: Why I'm Doubling Down On My Worst 2025 Pick - Seeking Alpha
- 14 days ago - Analysts Question Zoetis' Pathway To Growth As Key Segments Slide - Benzinga
- 14 days ago - Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand - Reuters
- 14 days ago - Zoetis Reports Fourth Quarter and Full Year 2025 Results - Business Wire